TEVA EBITDA

Teva Pharmaceutical Industries Limited American Depositary Shares · EBITDA

TEVA logo

TEVA EBITDA

Latest reported$2.59B
TEVA TTM EBITDA ($48.20M → $2.59B)
High-resolution chart · PNG

TEVA ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
2,594,000,000
3,270,000,000
3,346,000,000
3,876,000,000
2,979,000,000
2,568,000,000
1,670,000,000
2,025,000,000
2,445,000,000
3,169,000,000
3,917,000,000
1,814,000,000
1,926,000,000
1,965,000,000
793,000,000
1,610,000,000
1,910,000,000
1,799,000,000
2,978,000,000
3,864,000,000
-1,136,000,000
-1,480,000,000
-1,700,000,000
-1,701,000,000
2,592,000,000
1,844,000,000
1,831,000,000
-2,013,000,000
-1,227,000,000
-568,000,000
887,000,000
-8,965,000,000
-8,669,000,000
-14,297,000,000
-14,954,000,000
-2,475,000,000
-2,547,000,000
3,287,000,000
3,382,000,000
4,930,000,000
5,218,000,000
6,195,000,000
5,809,000,000
5,660,000,000
5,503,000,000
5,154,000,000
5,446,000,000
5,059,000,000
5,017,000,000
3,532,000,000
3,500,000,000
3,281,000,000
2,202,000,000
3,779,000,000
3,882,000,000
4,132,000,000
5,062,000,000
3,298,000,000
2,984,000,000
3,066,000,000
3,231,000,000
4,912,000,000
4,848,000,000
4,264,000,000
3,824,000,000
3,475,000,000
3,115,000,000
1,971,000,000
1,741,000,000
1,542,000,000
1,638,000,000
3,143,000,000
3,131,000,000
3,138,000,000
2,916,000,000
2,641,800,000
2,710,500,000
2,748,600,000
2,558,600,000
2,444,650,000
1,923,150,000
1,426,650,000
1,420,050,000
1,342,600,000
1,348,100,000
1,336,600,000
1,801,000,000
1,772,300,000
1,651,700,000
1,636,500,000
965,000,000
840,900,000
765,400,000
595,100,000
524,000,000
468,290,000
445,690,000
420,940,000
391,644,000
440,707,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.